Supports non-incremental, solutions-oriented research to reduce barriers in Alzheimer’s diagnosis, meaningful disease monitoring, and accurate prognosis. Clinical research is allowed but excludes clinical trials and animal research. Encourages leveraging existing cohorts, including younger populations. Requires preliminary data and community collaboration for studies enrolling human subjects. Includes a Career Initiation or Transition Partnership Option for collaborative projects.
Open to any type of entity with no explicit restrictions. At least one independent investigator must meet Career Initiation or Transition Partnership Option eligibility if applying under that option.
